Research map: Estrogen receptor signaling without estrogen: molecular insights into hormone resistance

Back to the article

Papers in this map

  1. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update · Kimberly H. Allison · 2020 · 1603 citations · Cited by this paper
  2. Association of vitamin D, HbA1c, and pain severity in T2DM patients with peripheral neuropathy · 2026 · Related
  3. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) · Fátima Cardoso · 2020 · 1400 citations · Cited by this paper
  4. Sex-specific vitamin D biomarkers in cardiovascular risk: beyond genetics toward personalized prevention · 2025 · Related
  5. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology · William John Gradishar · 2024 · 655 citations · Cited by this paper
  6. Hypothalamus-pituitary-adrenal axis in patients with post-traumatic stress disorders and related to oxidative stress · 2024 · Related
  7. Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance · Grazia Arpino · 2008 · 554 citations · Cited by this paper
  8. D-dimer – a multifaceted molecule · 2024 · Related
  9. Advances in the treatment of advanced oestrogen-receptor-positive breast cancer · Nicholas C. Turner · 2016 · 211 citations · Cited by this paper
  10. Hormonal disorders in autism spectrum disorders · 2025 · Related
  11. Estrogen Receptor Signaling in Breast Cancer · Paulina Anna Miziak · 2023 · 205 citations · Cited by this paper
  12. Interaction of thyroid hormonal imbalance, obesity, and Y-chromosomal gene dysregulation in male infertility: a case–control study · 2026 · Related
  13. First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer · François‐Clément Bidard · 2025 · 167 citations · Cited by this paper
  14. Association of serum NF-κB levels with peripheral neuropathy in type 2 diabetes mellitus patients: a pilot study · 2024 · Related
  15. Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer · Jonathan Thomas Lei · 2018 · 112 citations · Cited by this paper
  16. JN.1 variant in enduring COVID-19 pandemic: is it a variety of interest (VoI) or variety of concern (VoC)? · 2024 · Related
  17. Nexus between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer · Aditi Sanjay Khatpe · 2021 · 107 citations · Cited by this paper
  18. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with diabetic retinopathy in middle-aged Indians with type 2 diabetes mellitus · 2024 · Related
  19. ESR1 activating mutations: From structure to clinical application · Albert Grinshpun · 2022 · 68 citations · Cited by this paper
  20. Adrenocortical tissue dynamics and corticosteroid perturbation upon the experimental male estrogenization: reflections from animal and in vitro data about human treatment · 2026 · Related
  21. Mechanisms of endocrine resistance in hormone receptor-positive breast cancer · Yuan Gao · 2024 · 32 citations · Cited by this paper
  22. CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients · Stefania Crucitta · 2023 · 25 citations · Cited by this paper
  23. Somatic estrogen receptor α mutations that induce dimerization promote receptor activity and breast cancer proliferation · Seema Irani · 2023 · 24 citations · Cited by this paper
  24. ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy · Konstantinos Venetis · 2025 · 13 citations · Cited by this paper
  25. Elacestrant: who are optimal candidates for the first oral SERD? · M. Lipsyc-Sharf · 2023 · 12 citations · Cited by this paper
  26. ESR1 Fusions Invoke Breast Cancer Subtype-Dependent Enrichment of Ligand-Independent Oncogenic Signatures and Phenotypes · Megan E. Yates · 2024 · 8 citations · Cited by this paper
  27. Beyond endocrine resistance: estrogen receptor (ESR1) activating mutations mediate chemotherapy resistance through the JNK/c-Jun MDR1 pathway in breast cancer · Marwa Taya · 2024 · 7 citations · Cited by this paper
  28. Assessing endocrine resistance: monitoring circulating ESR1 mutations in Irosustat-treated ER positive breast cancer · Karen M. Page · 2025 · 1 citation · Cited by this paper
  29. Untitled · Cited by this paper
  30. Untitled · Cited by this paper

Source: OpenAlex (CC0)